• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL, a Veristat company, Senior Vice President to discuss orphan drug pricing at ITINERARE Symposium

Senior Vice President of SFL, Veristat company, Shayesteh Fürst-Ladani, in her role as President of the Rare Disease Action Forum (RDAF), will take part in the panel on orphan drug pricing during the ITINERARE Symposium organized by the University of Zurich ITINERARE on 1 December 2022. Together with the panelists she will discuss challenges to improve patient’s access to orphan drugs, explore potential solutions and sharing perspectives on the current challenges and potential solutions to streamline and simplify the process for orphan drug price setting.

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top